Member Content

Small Cap Pain Management Company Attractive on Valuation

by Joe Kunkle | Apr 18, 2025

Pacira (PCRX) authorized a $300M buyback Thursday after the close as a $1.14B company and has quietly been a strong 2025 performer with shares +30% YTD. PCRX traded to $80 in 2022 and in 2024 as low as $11 with shares currently forming a multi-week b...

Please login to continue reading this article.

Options Hawk Max

$399 | 30 days

Options Hawk Trading Hub Live Chat
Hawk’s Market Blitz
Spotlight Trades (2 Per Week)
Market Recap
Weekly Earnings Snapshots
Live Mock Portfolio
1 on 1 Access
Hawk’s Trader Toolbox
Street Research
OptionsHawk Research
Daily Options Radar
OptionHawk’s Weekly Radar Report
Options Hawk Market Outlook Access
Daily Earnings Grid
Weekly and Monthly OpEx Sheets
Notable Options Database
OptionsHawk Quarterly Market Brief

More About this Plan

Options Hawk Elite

$199 | 30 days

Hawk’s Market Blitz
Spotlight Trades (2 Per Week)
Market Recap
Weekly Earnings Snapshots
OptionsHawk Research
Daily Options Radar
OptionHawk’s Weekly Radar Report
Options Hawk Market Outlook Access
Daily Earnings Grid
OptionsHawk Quarterly Market Brief

More About this Plan